Reps. Doris Matsui, D-Calif., and Larry Bucshon, R-Ind., Jan. 12 introduced a of the Mapping America鈥檚 Pharmaceutical Supply Act, legislation that would require the Department of Health and Human Services to update its and create a database to help predict vulnerabilities in the U.S. pharmaceutical supply chain.

鈥淭he AHA appreciates the efforts of Representatives Matsui and Bucshon to address the chronic and increasing drug shortages hospitals, health systems and patients are facing across the country,鈥 said Lisa Kidder Hrobsky, AHA鈥檚 senior vice president, advocacy and political affairs. 鈥淭he AHA is proud to offer our strong support to this important bipartisan legislation that will strengthen the pharmaceutical supply chain for health care providers and patients and improve access to high-quality care.鈥

AHA last year voiced support for the Senate bill (S. 2364), sponsored by Sens. Gary Peters, D-Mich., James Lankford, R-Okla., and Mike Braun, R-Ind.

Related News Articles

Headline
The Government Accountability Office yesterday released a report calling for the Department of Health and Human Services to improve its efforts responding to鈥
Headline
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide鈥
Blog
The inability of many patients to obtain needed drug therapies due to either high prices or shortages has negatively affected patient outcomes.1 Nearly 30% of鈥
Headline
ASHP tracked a record 323 active drug shortages during the first quarter of 2024, surpassing the previous record of 320 shortages in 2014.鈥淪ome of the most鈥
Headline
The Department of Health and Human Services April 2 released a white paper proposing policy solutions for Congress and others to prevent drug shortages and鈥
Headline
In a statement submitted to the House Ways and Means Committee for a hearing Feb. 6 on chronic drug shortages, AHA recommended Congress enact legislation to鈥